Page 5 - Flipbook
P. 5
in partnership with
PARP inhibition for Prostate Cancer
Johann Sebastian de Bono
Regius Professor, Head of the Drug Development Unit,
The Institute of Cancer Research and Royal Marsden Hospital,
London, United Kingdom
CUA April 2022
